✦ LIBER ✦

PMH55 Payer Value in Alternative Treatment Formulations: Access to New Medicines in Schizophrenia

✍ Scribed by J. Morawski; N. Sweeney; T. Nijhuis

Book ID: 119312798
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 57 KB
Volume: 15
Category: Article
ISSN: 1098-3015
DOI: 10.1016/j.jval.2012.08.845

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A 3-Dimensional View of Access to Licens

A 3-Dimensional View of Access to Licensed and Subsidized Medicines under Single-Payer Systems in the US, the UK, Australia and New Zealand

✍ Ragupathy, Rajan; Aaltonen, Katri; Tordoff, June; Norris, Pauline; Reith, David 📂 Article 📅 2012 🏛 Springer International Publishing AG 🌐 English ⚖ 200 KB

PHP14 THE EFFECTS OF PHARMACEUTICAL COST

PHP14 THE EFFECTS OF PHARMACEUTICAL COST CONTAINMENT ON ACCESS TO LICENSED AND SUBSIDIZED MEDICINES UNDER SINGLE PAYER SYSTEMS IN THE UNITED STATES, UNITED KINGDOM, AUSTRALIA AND NEW ZEALAND

✍ R. Ragupathy; K. Aaltonen; J. Tordoff; P. Norris; D. Reith 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 55 KB

Do rheumatoid arthritis patients have eq

Do rheumatoid arthritis patients have equal access to treatment with new medicines? Tumour necrosis factor-alpha inhibitors use in four European countries

✍ Joëlle M. Hoebert; Aukje K. Mantel-Teeuwisse; Liset van Dijk; Johannes W.J. Bijl 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 339 KB